Attached files

file filename
8-K - 8-K - AXCELIS TECHNOLOGIES INCa12-25688_18k.htm

Exhibit 99.1

 

GRAPHIC

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2012

 

BEVERLY, Mass. — November 1, 2012—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the quarter ended September 30, 2012. The Company reported third quarter revenue of $44.6 million, compared to $59.1 million for the second quarter of 2012. Net loss for the quarter was $8.7 million, or $0.08 per diluted share, which includes a $0.6 million or $.01 per share restructuring charge. This compares to a net loss for the second quarter of 2012 of $0.5 million, or $0.00 per share, which included a $0.2 million restructuring charge. Cash and cash equivalents were $35.2 million at September 30, 2012 compared with $33.8 million at June 30, 2012.

 

Commenting on the Company’s performance, Chairman and CEO Mary Puma said, “Although industry conditions remained difficult during the third quarter, we continued to seed the market with product penetrations, including shipping our first Purion M medium current implant evaluation system. In addition, we contained spending and realized a modest increase in cash. These actions will position the company well as industry trends improve.”

 

Third Quarter 2012 Conference Call

The Company will host a conference call today at 5:00 pm ET to discuss results for the third quarter of 2012.  An audio webcast will be available on the Investor page of Axcelis’ website at www.axcelis.com, or by dialing 1.888.713.4199 (1.617.213.4861 outside North America).  Participants calling into the conference call will be requested to provide the passcode:  87434251. A replay of the webcast will be available for 30 days following the conference call.

 

Safe Harbor Statement

 

The conference call will contain forward-looking statements under the SEC safe harbor provisions. These statements, which include our guidance for future financial performance, are

 

1



 

based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis

 

Axcelis Technologies, Inc. (Nasdaq: ACLS) headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation and cleaning systems. The Company’s Internet address is: www.axcelis.com.

 

Company Contacts

 

Financial Community:

Jay Zager
978.787.9408

 

Editorial/Media Community:

Maureen Hart
978.787.4266

 

2



 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2012

 

2011

 

2012

 

2011

 

Revenue

 

 

 

 

 

 

 

 

 

Product

 

$

37,093

 

$

64,350

 

$

136,096

 

$

235,287

 

Service

 

7,547

 

8,105

 

22,664

 

23,718

 

Total revenue

 

44,640

 

72,455

 

158,760

 

259,005

 

Cost of revenue

 

 

 

 

 

 

 

 

 

Product

 

24,809

 

40,055

 

84,692

 

149,833

 

Service

 

5,464

 

5,505

 

16,377

 

17,058

 

Total cost of revenue

 

30,273

 

45,560

 

101,069

 

166,891

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

14,367

 

26,895

 

57,691

 

92,114

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

9,851

 

11,389

 

31,999

 

35,036

 

Sales and marketing

 

5,470

 

7,237

 

18,284

 

22,731

 

General and administrative

 

6,325

 

8,458

 

20,611

 

25,929

 

Restructuring charges

 

578

 

 

3,612

 

 

Total operating expenses

 

22,224

 

27,084

 

74,506

 

83,696

 

Income (loss) from operations

 

(7,857

)

(189

)

(16,815

)

8,418

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest income

 

9

 

7

 

27

 

24

 

Other, net

 

(627

)

1,563

 

(999

)

(45

)

Total other income (expense)

 

(618

)

1,570

 

(972

)

(21

)

 

 

 

 

 

 

 

 

 

 

Income (loss) before income taxes

 

(8,475

)

1,381

 

(17,787

)

8,397

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

243

 

230

 

1,429

 

1,207

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(8,718

)

$

1,151

 

$

(19,216

)

$

7,190

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic and diluted net income (loss) per share

 

$

(0.08

)

$

0.01

 

$

(0.18

)

$

0.07

 

 

 

 

 

 

 

 

 

 

 

Shares used in computing basic and diluted net income (loss) per share

 

 

 

 

 

 

 

 

 

Basic weighted average common shares

 

107,855

 

106,417

 

107,521

 

106,152

 

Diluted weighted average common shares

 

107,855

 

108,192

 

107,521

 

109,452

 

 

3



 

Axcelis Technologies, Inc.

Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2012

 

2011

 

2012

 

2011

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(8,718

)

$

1,151

 

$

(19,216

)

$

7,190

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

1,105

 

(3,999

)

(308

)

(1,034

)

Comprehensive income (loss)

 

$

(7,613

)

$

(2,848

)

$

(19,524

)

$

6,156

 

 

4



 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands)

(Unaudited)

 

 

 

September 30,
2012

 

December 31,
2011

 

ASSETS

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

35,220

 

$

46,877

 

Accounts receivable, net

 

24,978

 

35,071

 

Inventories, net

 

123,280

 

120,023

 

Prepaid expenses and other current assets

 

4,973

 

10,062

 

Total current assets

 

188,451

 

212,033

 

 

 

 

 

 

 

Property, plant and equipment, net

 

35,107

 

37,204

 

Long-term restricted cash

 

103

 

104

 

Other assets

 

12,928

 

19,904

 

Total assets

 

$

236,589

 

$

269,245

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

 

$

11,683

 

$

19,551

 

Accrued compensation

 

7,175

 

8,285

 

Warranty

 

2,107

 

3,556

 

Income taxes

 

356

 

495

 

Deferred revenue

 

6,641

 

10,786

 

Other current liabilities

 

3,711

 

4,799

 

Total current liabilities

 

31,673

 

47,472

 

 

 

 

 

 

 

Long-term deferred revenue

 

544

 

1,488

 

Other long-term liabilities

 

4,944

 

5,730

 

Total liabilities

 

37,161

 

54,690

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred stock

 

 

 

Common stock

 

108

 

107

 

Additional paid-in capital

 

503,728

 

499,332

 

Treasury stock

 

(1,218

)

(1,218

)

Accumulated deficit

 

(307,659

)

(288,443

)

Accumulated other comprehensive income

 

4,469

 

4,777

 

Total stockholders’ equity

 

199,428

 

214,555

 

Total liabilities and stockholders’ equity

 

$

236,589

 

$

269,245

 

 

5



 

Axcelis Technologies, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine months ended
September 30,

 

 

 

2012

 

2011

 

Cash flows from operating activities:

 

 

 

 

 

Net income (loss)

 

$

(19,216

)

$

7,190

 

Adjustments to reconcile net income (loss) to net cash (used for) provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

5,419

 

6,180

 

Deferred taxes

 

998

 

75

 

Stock-based compensation expense

 

3,411

 

3,644

 

Provision for excess inventory

 

678

 

661

 

Changes in operating assets & liabilities

 

 

 

 

 

Accounts receivable

 

10,143

 

17,994

 

Inventories

 

(3,496

)

(13,384

)

Prepaid expenses and other current assets

 

4,490

 

5,910

 

Accounts payable & other current liabilities

 

(11,601

)

(15,237

)

Deferred revenue

 

(5,089

)

(4,339

)

Income taxes

 

(135

)

798

 

Other assets and liabilities

 

3,025

 

(8,640

)

Net cash (used for) provided by operating activities

 

(11,373

)

852

 

Cash flows from investing activities:

 

 

 

 

 

Expenditures for property, plant, and equipment

 

(536

)

(1,950

)

Decrease in restricted cash

 

1

 

 

Net cash used for investing activities

 

(535

)

(1,950

)

Cash flows from financing activities:

 

 

 

 

 

Financing fees and other expenses

 

 

(199

)

Proceeds from exercise of stock options

 

863

 

272

 

Proceeds from Employee Stock Purchase Plan

 

179

 

275

 

Net cash provided by financing activities

 

1,042

 

348

 

Effect of exchange rate changes on cash

 

(791

)

(580

)

Net decrease in cash and cash equivalents

 

(11,657

)

(1,330

)

Cash and cash equivalents at beginning of period

 

46,877

 

45,743

 

Cash and cash equivalents at end of period

 

$

35,220

 

$

44,413

 

 

6